BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

828 related articles for article (PubMed ID: 12395148)

  • 1. Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura.
    Tsai HM
    J Mol Med (Berl); 2002 Oct; 80(10):639-47. PubMed ID: 12395148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deficiency of ADAMTS13 in thrombotic thrombocytopenic purpura.
    Tsai HM
    Int J Hematol; 2002 Aug; 76 Suppl 2():132-8. PubMed ID: 12430913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [From gene to disease; congenital thrombotic thrombocytopenic purpura due to mutations in the ADAMTS13 gene].
    Schiphorst RH; van de Kar NC; van den Heuvel LP
    Ned Tijdschr Geneeskd; 2003 Dec; 147(49):2422-4. PubMed ID: 14694551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. von Willebrand factor, ADAMTS-13, and thrombotic thrombocytopenic purpura.
    Moake JL
    Semin Hematol; 2004 Jan; 41(1):4-14. PubMed ID: 14727254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura.
    Levy GG; Nichols WC; Lian EC; Foroud T; McClintick JN; McGee BM; Yang AY; Siemieniak DR; Stark KR; Gruppo R; Sarode R; Shurin SB; Chandrasekaran V; Stabler SP; Sabio H; Bouhassira EE; Upshaw JD; Ginsburg D; Tsai HM
    Nature; 2001 Oct; 413(6855):488-94. PubMed ID: 11586351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanisms in thrombotic thrombocytopenic purpura.
    Tsai HM
    Semin Thromb Hemost; 2004 Oct; 30(5):549-57. PubMed ID: 15497097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
    Furlan M; Robles R; Galbusera M; Remuzzi G; Kyrle PA; Brenner B; Krause M; Scharrer I; Aumann V; Mittler U; Solenthaler M; Lämmle B
    N Engl J Med; 1998 Nov; 339(22):1578-84. PubMed ID: 9828245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in thrombotic thrombocytopenic purpura.
    Sadler JE; Moake JL; Miyata T; George JN
    Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic defects leading to hereditary thrombotic thrombocytopenic purpura.
    Kokame K; Miyata T
    Semin Hematol; 2004 Jan; 41(1):34-40. PubMed ID: 14727257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interplay between ADAMTS13 and von Willebrand factor in inherited and acquired thrombotic microangiopathies.
    Soejima K; Nakagaki T
    Semin Hematol; 2005 Jan; 42(1):56-62. PubMed ID: 15662617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Genetic polymorphism of von Willebrand factor (VWF)-cleaving protease, ADAMTS13].
    Kokame K
    Brain Nerve; 2008 Nov; 60(11):1325-32. PubMed ID: 19069166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura.
    Tsai HM; Lian EC
    N Engl J Med; 1998 Nov; 339(22):1585-94. PubMed ID: 9828246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Keeping von Willebrand Factor under Control: Alternatives for ADAMTS13.
    Tersteeg C; Fijnheer R; Pasterkamp G; de Groot PG; Vanhoorelbeke K; de Maat S; Maas C
    Semin Thromb Hemost; 2016 Feb; 42(1):9-17. PubMed ID: 26595154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet activation and the formation of the platelet plug: deficiency of ADAMTS13 causes thrombotic thrombocytopenic purpura.
    Tsai HM
    Arterioscler Thromb Vasc Biol; 2003 Mar; 23(3):388-96. PubMed ID: 12615692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deficient activity of von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura.
    Furlan M
    Expert Rev Cardiovasc Ther; 2003 Jul; 1(2):243-55. PubMed ID: 15030284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Von Willebrand factor, ADAMTS-13, and thrombotic thrombocytopenic purpura.
    Zhou Z; Nguyen TC; Guchhait P; Dong JF
    Semin Thromb Hemost; 2010 Feb; 36(1):71-81. PubMed ID: 20391298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An enzyme immunoassay of ADAMTS13 distinguishes patients with thrombotic thrombocytopenic purpura from normal individuals and carriers of ADAMTS13 mutations.
    Zhou W; Tsai HM
    Thromb Haemost; 2004 Apr; 91(4):806-11. PubMed ID: 15045144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease.
    Furlan M; Lämmle B
    Best Pract Res Clin Haematol; 2001 Jun; 14(2):437-54. PubMed ID: 11686108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of ADAMTS13 in the pathogenesis of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.
    George JN
    Clin Adv Hematol Oncol; 2005 Aug; 3(8):627-32. PubMed ID: 16167049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Von Willebrand factor-cleaving protease and Upshaw-Schulman syndrome.
    Fujimura Y; Matsumoto M; Yagi H; Yoshioka A; Matsui T; Titani K
    Int J Hematol; 2002 Jan; 75(1):25-34. PubMed ID: 11843286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.